Harvard Bioscience Raises FY2026 Sales Guidance from $88.281M-$90.012M to $89.147M-$90.877M vs $89.794M Est

Harvard Bioscience (NASDAQ:HBIO) raises FY2026 sales outlook from $88.281 million-$90.012 million to $89.147 million-$90.877 million vs $89.794 million estimate.